Clinical Trial Update: Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of atomoxetine hydrochloride for attention-deficit/hyperactivity disorder in children and adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Dyslexia

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention-Deficit/Hyperactivity Disorder, Comorbid Dyslexia | Phase 4 | Status: COMPLETED